Drugs / YBSW015
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05369754 | Jul 2022 → Jan 2023 | COVID-19 | Yabao Pharmaceutical Group | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YBSW015 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05369754 ↗ |
| Route | Intravenous | “Prepared YBSW015 injection is intravenously injected by an infusion pump or gravity infusion” NCT05369754 ↗ |